Insider Transactions in Q2 2020 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2020
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.38%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.51%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.75%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
William Richard White Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+35.42%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
Jonathan Young Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.67%
|
$21,165
$17.07 P/Share
|